Regencell Bioscience Holdings Limited (RGC)
Nasdaq: RGC · Medicinal Chemicals & Botanical Products · Hong Kong · filing with the SEC since 2020
The company now
Regencell Bioscience Holdings Limited is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Hong Kong. In its latest annual figures on file, for the fiscal year ended 2026-06-30, it reported a loss of $12 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.